menu
    • menu

    Company profile for Inventiva Pharma

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. We have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant exp...
    We are a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. We have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inventiva PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    50 rue de Dijon 21121 Daix,
    Telephone
    Telephone
    +33 (0)3 80 44 75 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inventivapharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/inventiva-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/inventivapharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inventiva Reports 2025 Full-Year Results And Business Update
    Inventiva Reports 2025 Full-Year Results And Business Update

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265019/0/en/Inventiva-reports-2025-full-year-results-and-provides-a-business-update.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Inventiva Presentation of its 2025 Full-Year Financial Results
    Inventiva Presentation of its 2025 Full-Year Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260878/0/en/Inventiva-Schedules-the-Publication-and-Presentation-of-its-2025-Full-Year-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Inventiva Reports Preliminary 2025¹ Fiscal Year Financial Results
    Inventiva Reports Preliminary 2025¹ Fiscal Year Financial Results

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3238953/0/en/Inventiva-reports-preliminary-2025-fiscal-year-financial-results.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Inventiva To Present At Guggenheim Biotech Summit 2026
    Inventiva To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232443/0/en/Inventiva-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug
    Inventiva's 50% Surge Shows Investor Optimism Over Liver Drug

    28 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/biotech-inventivas-50-surge-shows-investor-optimism-over-liver-disease-drug-2026-01-28/

    REUTERS
    28 Jan 2026
    Share Share
    Inventiva Reviews Half-Year Liquidity Deal with Kepler Cheuvreux
    Inventiva Reviews Half-Year Liquidity Deal with Kepler Cheuvreux

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225966/0/en/Half-Year-Review-of-Inventiva-s-Liquidity-Contract-with-Kepler-Cheuvreux.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search